Archive for December 25th, 2009
“Attempted Act Of Terrorism” On Board Flight To Detroit
At first the official story about a Delta flight into Detroit was that a passenger intended to light up fireworks close to landing.
However, it’s now being reported that the passenger — a Nigerian citizen who claims to be an Al Qaeda member — was actually attempting to blow up the plane.
If true, the attempt was a pathetic flop, and whatever explosive it was apparently so insignificant and weak that everyone thought it was a firecracker.
Update: According to Marc Ambinder, the White House is now calling the incident an “attempted act of terrorism.”
Join the conversation about this story »
See Also:
- American Airlines Jet Skids Off Runway In Jamaica And Stops 10 Feet From Sea
- Terrorism Possible In Russian Train Derailment That Killed Dozens
- As Obama Weighs Afghanistan Surge, Presumed-Dead Al-Qaeda Leader Warns Of Trap
The Sloppiest Drug Companies of 2009 (GENZ)
As healthcare reform hits a historical turning point (for better or worse), Jim Edwards at BNET Pharma reminisces about some of the most screwed up drug companies’ in 2009.
They’re a nice reminder of how dangerous investing in drug companies can be. You really never know what kind of huge, random disaster is going to pop up.
Such as this:
Genzyme (GENZ) - Your company holds a monopoly on a drug for Gaucher’s disease. It’s a license to print money. How do you screw this up? Do what what Genzyme did: Introduce a bunch of garbage — literally bits of rubber and metal — into your drugs. Have this come after one of your sites was infected with a virus. Get two new drugs rejected by the FDA and have a third one dropped during R&D. Meanwhile, make sure your CEO spends the year enriching himself with a $10 million stock sale on top of $50 million in compensation over the previous three years. That’s why Genzyme ended the year with Genzyme’s founder calling for CEO Henri Termeer to resign.
Continue reading the five worst drug companies at BNET Pharma >>
Join the conversation about this story »
See Also:
- Drug Prices Don’t Fall Because Medicare Isn’t Allowed To Bargain
- Drug Advertising Is Completely Broken
- Pharma Exec Convicted Of Pushing Alternative Uses For Drug